Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When MarketBeat Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On ...

Upstream Bio has become the latest ... the initial public offering (IPO) queue amid a flurry of IPO activity in the sector, with three biotechs listing on the Nasdaq last week – Bicara ...

Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report)’s stock ... In other Upstream Bio news, major shareholder Ai Upstream Llc acquired 1,175,000 shares of the business’s stock in a transaction ...

Upstream Bio (NASDAQ:UPB – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Upstream Bio to post earnings of ...